BE848280A - Nouveaux composes imidazoles, procede pour leur preparation et medicaments les contenant - Google Patents

Nouveaux composes imidazoles, procede pour leur preparation et medicaments les contenant

Info

Publication number
BE848280A
BE848280A BE172306A BE172306A BE848280A BE 848280 A BE848280 A BE 848280A BE 172306 A BE172306 A BE 172306A BE 172306 A BE172306 A BE 172306A BE 848280 A BE848280 A BE 848280A
Authority
BE
Belgium
Prior art keywords
preparation
products containing
medicinal products
new imidazoles
compounds
Prior art date
Application number
BE172306A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE848280A publication Critical patent/BE848280A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE172306A 1975-11-13 1976-11-12 Nouveaux composes imidazoles, procede pour leur preparation et medicaments les contenant BE848280A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550959A DE2550959C3 (de) 1975-11-13 1975-11-13 Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
BE848280A true BE848280A (fr) 1977-05-12

Family

ID=5961645

Family Applications (1)

Application Number Title Priority Date Filing Date
BE172306A BE848280A (fr) 1975-11-13 1976-11-12 Nouveaux composes imidazoles, procede pour leur preparation et medicaments les contenant

Country Status (21)

Country Link
US (1) US4152440A (fr)
JP (3) JPS5262278A (fr)
AT (1) AT357155B (fr)
AU (1) AU504009B2 (fr)
BE (1) BE848280A (fr)
CA (1) CA1097350A (fr)
DE (1) DE2550959C3 (fr)
DK (1) DK511376A (fr)
ES (1) ES453276A1 (fr)
FI (1) FI763215A (fr)
FR (1) FR2363328A1 (fr)
GB (1) GB1545939A (fr)
GR (1) GR70648B (fr)
HU (1) HU173879B (fr)
IE (1) IE44184B1 (fr)
IL (1) IL50892A (fr)
LU (1) LU76188A1 (fr)
NL (1) NL7612610A (fr)
NO (1) NO763876L (fr)
SE (1) SE7612685L (fr)
ZA (1) ZA766715B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071866A (en) * 1989-07-31 1991-12-10 Bristol-Myers Squibb Company Arylpyrazole derivatives as anti-platelet agents
WO2006002236A1 (fr) * 2004-06-18 2006-01-05 Novartis Vaccines And Diagnostics Inc. Derives de n-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl) benzamide et composes associes comme inhibiteurs de la proteine kinesine fuseau (ksp) pour le traitement du cancer
KR20090097210A (ko) * 2007-01-05 2009-09-15 노파르티스 아게 키네신 방추체 단백질 (eg-5) 억제제로서의 이미다졸 유도체
WO2008153129A1 (fr) * 2007-06-14 2008-12-18 Teijin Pharma Limited Agent pour abaisser le taux d'acide urique
CN102186833A (zh) * 2008-08-18 2011-09-14 耶鲁大学 Mif调节剂
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
EP2508511A1 (fr) 2011-04-07 2012-10-10 Laboratoire Biodim Inhibiteurs de la réplication virale, leur procédé de préparation et leurs utilisations thérapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470085A (en) * 1947-03-07 1949-05-17 Bilhuber Inc E Substituted amino alkyl tetrazoles
BE535047A (fr) * 1954-01-21
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
SE7408483L (fr) * 1973-07-27 1975-01-28 Ciba Geigy Ag
DE2362171A1 (de) * 1973-12-14 1975-06-26 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)heteroaryl-verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ATA844476A (de) 1979-11-15
FI763215A (fr) 1977-05-14
NL7612610A (nl) 1977-05-17
NO763876L (fr) 1977-05-16
HU173879B (hu) 1979-09-28
AT357155B (de) 1980-06-25
DK511376A (da) 1977-05-14
JPS5531155B2 (fr) 1980-08-15
GB1545939A (en) 1979-05-16
FR2363328B1 (fr) 1979-08-31
IL50892A0 (en) 1977-01-31
FR2363328A1 (fr) 1978-03-31
CA1097350A (fr) 1981-03-10
US4152440A (en) 1979-05-01
AU1952576A (en) 1978-05-18
JPS54163578A (en) 1979-12-26
IE44184L (en) 1977-05-13
IE44184B1 (en) 1981-09-09
JPS5262278A (en) 1977-05-23
ZA766715B (en) 1977-10-26
DE2550959C3 (de) 1980-12-04
AU504009B2 (en) 1979-09-27
IL50892A (en) 1981-02-27
DE2550959A1 (de) 1977-05-26
GR70648B (fr) 1982-12-03
ES453276A1 (es) 1978-02-01
DE2550959B2 (de) 1980-04-10
LU76188A1 (fr) 1977-06-06
JPS5547677A (en) 1980-04-04
SE7612685L (sv) 1977-05-14

Similar Documents

Publication Publication Date Title
BE846104A (fr) Nouveaux benzylates quaternaires de n-alcoyl-nortropines n-b-substituees, procede pour leur preparation et medicament en renfermant
FR2306703A1 (fr) Nouveaux derives d'erythromycine, procede pour leur preparation et medicaments les renfermant
FR2297037A1 (fr) Nouveaux derives de biphenyloxy, medicaments les contenant et procede pour leur preparation
BE847482A (fr) Nouvelles 4-aminopyrazoles substituees, procede pour leur preparation et medicaments contenant ces composes
BE795997A (fr) Nouveaux derives de l'insuline, leur procede de preparation et medicaments les contenant
BE885268A (fr) Nouveaux n-propionyl-sarcosine-anilides, procede pour leur preparation et medicaments les contenant
FR2346324A1 (fr) Nouvelles amidino-urees, procede pour leur preparation et medicaments les renfermant
BE857289A (fr) 2-benzyl-pyrrolidines, procede pour leur preparation et medicaments contenant ces composes
BE829417A (fr) Nouveaux pyrimidinols, leur procede de preparation et medicament les contenant
FR2303538A1 (fr) Nouveaux ethers cycliques, leur procede de preparation et medicament les contenant
BE862278A (fr) Nouveaux composes heterocycliques, leur procede de preparation et medicament les contenant
BE848280A (fr) Nouveaux composes imidazoles, procede pour leur preparation et medicaments les contenant
BE804092A (fr) Nouveaux 1-ethyl-imidazoles, leur procede de preparation et medicaments les contenant
FR2290211A1 (fr) Nouveaux 1,1-bioxydes de 4-hydroxy-2h-naphto (2,1-e)-1,2-thiazine-3-carboxamides, leur procede de preparation et medicaments les renfermant
BE805210A (fr) Nouveaux amides d'acides imidazoiylacetiques, leur procede de preparation et medicaments les contenant
FR2274288A1 (fr) Nouveaux composes arylsulfonylcarbamoyl-1,3-dicarbonyliques, leur procede de preparation et medicament les contenant
BE859949A (fr) Nouveaux derives thiazoliques leur procede de preparation et medicament antherminthique les contenant
FR2292474A1 (fr) Nouveaux diaryloxy-imidazolyl-o,n-acetals, leur procede de preparation et medicament les contenant
FR2322589A1 (fr) Sulfoximides substitues, procede pour leur production et medicaments contenant ces composes
BE840431A (fr) Nouveaux derives d'erythromycine, procede pour leur preparation et medicaments les renfermant
BE846397A (fr) Nouvelles 2,4-diamino-5-benzyl-pyrimidines, procede pour leur preparation et medicaments contenant ces composes
BE827119A (fr) Nouveaux 1-arylucaciles, leur procede de preparation et medicament les contenant
BE843342A (fr) Nouveaux composes de beta-lactame, leur procede de preparation et medicament les contenant
BE862330A (fr) Nouveaux dehydro-oligopeptides, leur procede de preparation et medicaments les contenant
BE861687A (fr) Nouveaux dithiosalicylamides porterus de groupes alkyliques basiques, leur procede de preparation et medicament les contenant